Introduction:Basic information about CAS 154164-30-4|YM 90K hydrochloride, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | YM 90K hydrochloride |
|---|
| CAS Number | 154164-30-4 | Molecular Weight | 309.665 |
|---|
| Density | / | Boiling Point | 556.6ºC at 760mmHg |
|---|
| Molecular Formula | C11H8ClN5O4 | Melting Point | / |
|---|
| MSDS | / | Flash Point | 290.4ºC |
|---|
Names
| Name | 6-imidazol-1-yl-7-nitro-1,4-dihydroquinoxaline-2,3-dione,hydrochloride |
|---|
| Synonym | More Synonyms |
|---|
YM 90K hydrochloride BiologicalActivity
| Description | YM90K is a potent and selective AMPA receptor antagonist with a Ki of 84 nM. YM90K is less potent in inhibiting kainate (Ki of 2.2 μM) and NMDA (Ki of 37 μM) receptors. YM90K has neuroprotective actions[1]. |
|---|
| Related Catalog | Signaling Pathways >>Neuronal Signaling >>iGluRResearch Areas >>Neurological DiseaseSignaling Pathways >>Membrane Transporter/Ion Channel >>iGluR |
|---|
| Target | Ki: 84 nM (AMPA receptor), 2.2 μM (Kainate receptor) and 37 μM (NMDA receptor)[1] |
|---|
| In Vitro | YM90K (30 nmol) co-injected with AMPA or kainate into the rat striatum protected cholinergic neurons against AMPA- or kainate-induced neurotoxicity[1]. |
|---|
| In Vivo | YM90K showes potent suppressive activity against audiogenic seizure in DBA/2 mice; ED50 values of YM90K against tonic seizure is 2.54 mg/kg (i.p.). The duration of the anticonvulsant effects of YM90K is 30 min[1]. In a global ischemia model, YM90K (15 mg/kg i.p. x 3) significantly prevents the delayed neuronal death in the hippocampal CA1 region in Mongolian gerbils when administered 1 h after 5-min ischemia. The therapeutic time window for the neuroprotective effect of YM90K (30 mg/kg i.p. x 3) is 6 h[1]. In a focal ischemia model, YM90K (30 mg/kg i.v. bolus+10 mg/kg/h for 4 h) reduces the volume of ischemic damage in the cerebral cortex in F344 rats[1]. |
|---|
| References | [1]. M Shimizu-Sasamata, et al. YM90K: pharmacological characterization as a selective and potent alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist. J Pharmacol Exp Ther. 1996 Jan;276(1):84-92. |
|---|
Chemical & Physical Properties
| Boiling Point | 556.6ºC at 760mmHg |
|---|
| Molecular Formula | C11H8ClN5O4 |
|---|
| Molecular Weight | 309.665 |
|---|
| Flash Point | 290.4ºC |
|---|
| Exact Mass | 309.026489 |
|---|
| PSA | 129.36000 |
|---|
| LogP | 1.63550 |
|---|
| Index of Refraction | 1.84 |
|---|
| InChIKey | UMLFDVOHVJPDIZ-UHFFFAOYSA-N |
|---|
| SMILES | Cl.O=c1[nH]c2cc(-n3ccnc3)c([N+](=O)[O-])cc2[nH]c1=O |
|---|
Synonyms
| N-Acetyltryptamine |
| C11H7N5O4 |
| YM 90K |
| ym 900 |
| 2,3-Quinoxalinedione, 1,4-dihydro-6-(1H-imidazol-1-yl)-7-nitro-, hydrochloride (1:1) |
| 6-(1H-Imidazol-1-yl)-7-nitro-1,4-dihydro-2,3-quinoxalinedione hydrochloride (1:1) |